TQB3019 Capsule

TQB3019 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3019 Capsule, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors [Phase 1]

See pricing